Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2026-02-12 @ 9:58 AM
Study NCT ID:
NCT05312632
Status:
COMPLETED
Last Update Posted:
2024-09-23
First Post:
2022-03-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea
Sponsor:
Eisai Korea Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ME2125-M082-401
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None